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Regular screening for microalbuminuria among type 2 diabetes patients is less 
common in most low-income countries while it is an early marker of diabetic 
nephropathy and cardiovascular complications. 
Objective 
This study aims to assess the need for regular screening for microalbuminuria 
among type 2 diabetes patients.  
Methodology 
 with cross-sectional approach, 124 diabetic patients were recruited at 
Muhimbili National Hospital, in Tanzania; their age, gender, body mass index, 
fasting blood sugar levels (by Accu Chek Active Glucometer), random urine 
albumin levels (by Microalbumin 2-1 Combo Test Strips), and the duration of 
diabetes were recorded.  
Results 
The study indicated that 62.1% of the participants were microalbuminuric while 
2.4% were macroalbuminuric. The risk of microalbuminuria was 4.55 higher in 
patients aged 60-69 years (95% CI: 1.32-16.51), and 17.4 times higher in 
patients aged 70 and above (95% CI: 1.49-202.86) compared to individuals aged 
below 50 years. Patients with high blood sugar level had a risk of 8.09 times 
higher compared to those with normal blood sugar (CI: 2.53-25.86). Also, the 
odds were 7.89 higher in patients who lived with diabetes for 10-14 years 
compared to those lived with the disease less than 5 years (95% CI:1.33-45.59).  





The odds of microalbuminuria increased significantly as the patient gets older, 
with high blood sugar, and the duration of diabetes. Health policies need to 
establish programs that enhance care at the diabetic clinic through regular 
screening for microalbuminuria to reduce the risk of developing kidney and 
cardiovascular complications. 
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Introduction 
The world and Sub-Saharan Africa, 
in particular, are experiencing a high 
increase of non-communicable 
diseases which will continue to lead 
as the cause of mortality and 
morbidity until 2030.[1] Currently, 
type 2 diabetes mellitus is already on 
top of reported non-communicable 
diseases and the main cause of 
chronic illness and deaths 
worldwide, and it is causing 
premature deaths, especially in low-
income countries. For instance, in 
2013, the majority of deaths caused 
by diabetes worldwide were among 
people under the age of 60 years, and 
the sub-Saharan Africa region 
accounted for 75% of these deaths.[2] 
The data from the International 
Diabetes Federation in 2009 shows 
that more than 371 million people 
globally had diabetes, and this 
number is predicted to increase to 
over 550 million by 2030, with a large 
number living in low-and middle-
income countries.[3] For instance, in 
2006, the Tanzania Diabetes 
Association (TDA) estimated that 
there were more than 400,000 people 
with diabetes.[4] 
Diabetes mellitus, defined as 
persistent hyperglycemia, reflects 
derangements in carbohydrates, fats, 
and protein metabolism which itself 
is a consequence of insulin 
deficiency, insulin resistance, or 
both.[5] Type 2 diabetes mellitus 
(T2DM) is common among middle-
aged and older people, although it 
can occur at any age.[6] It is mostly 
associated with insulin resistance 
and impacts the main organs 
involved in the carbohydrates and 
lipids metabolism. T2DM induces 
glucose production in the liver and 
overproduction of free fatty acids by 
fat cells and also impedes glucose 
uptake in both liver and skeletal 
muscle.[7] Insulin deficiency occurs 
following the gradual failure of beta-
cells which produce an insufficient 
amount of insulin.[8] Most of the 
people with T2DM live with it for a 
long time unknowingly as the disease 
remains asymptomatic until the 
individual shows signs of diabetes 
complications. The excess of blood 




glucose, as it takes years to appear or 
be recognized, silently, destroys the 
body.[6] The metabolic derangements 
of long duration, progressively affect 
the integrity of body cells and 
sometimes lead to the permanent 
loss of function for some organs of 
the body. The first to be affected is 
the vascular system due to high 
blood glucose levels and other 
abnormal metabolites present in the 
blood which induce endothelial 
dysfunction. The dysfunctional 
endothelium is at the heart of 
developing diabetes complications.[9] 
These complications mainly include 
cardiovascular diseases, diabetic 
neuropathy, amputations, renal 
failure, and blindness.[3] 
The majority of the causes of 
morbidity and mortality among 
diabetic patients result from 
microalbuminuria because of its 
association with cardiovascular 
diseases, proliferative retinopathy, 
peripheral neuropathy, and renal 
impairments, which, when not 
controlled, lead to end-stage renal 
disease (ESRD).[10] Many people 
with T2DM will show 
microalbuminuria at the time of 
diabetes diagnosis.[11] Studies 
indicated that up to 30% of people 
newly diagnosed with T2DM have an 
abnormal amount of albumin protein 
in the urine, an indication that they 
may have overt proteinuria even at 
diagnosis.[12] 
Several studies indicated 
microalbuminuria as the first sign of 
diabetic nephropathy. It develops in 
the very early stages of diabetes 
mellitus even when the glomerular 
filtration rate (GFR) is still 
normal.[13] This stage is very critical 
in the management of diabetes as 
studies have shown that when 
microalbuminuria is detected early, 
it is easily addressed to prevent the 
future development of overt diabetic 
nephropathy.[12,14]  
Microalbuminuria does not have 
symptoms in the earliest stages. 
Therefore, it is essential to screen for 
it among T2DM patients to offer 
optimal protective therapy against 
renal failure and cardiovascular 
events.[15,16] However, the 
screening is not common in Sub-
Saharan Africa even though diabetes 
is already a serious health challenge 
in the region.[17] This study intended 
to assess the need for regular 
screening for microalbuminuria 
among type 2 diabetes patients by 
determining its magnitude and its 
correlates among those attending the 
outpatient clinic at Muhimbili 
National Hospital in Tanzania. 
Methods 
Study design, setting, and 
population 
The study used a cross-sectional 
design. Data were collected from 
December 2014 to January 2015 




among outpatients diagnosed with 
T2DM that attended the diabetes 
clinic of Muhimbili National Hospital 
(MNH), the largest hospital in 
Tanzania located in Dar es Salaam 
city. The clinic receives T2DM 
patients twice a week, about 60 
patients a day. Patients see a doctor 
for follow-up once in three to five 
months, the attendance pattern can 
change depending on the status of 
the disease.   
Sample size and sampling 
procedure 
The study involved 124 participants 
calculated using the formula 
designed for cross-sectional studies. 
As a reference, we used the 
prevalence of microalbuminuria 
among type 2 diabetes patients found 
by a study done at Kilimanjaro 
Christian Medical Centre (KCMC) in 
Tanzania (29%).[18] A convenient 
sampling procedure was used to 
collect data; participants were 
recruited based on their scheduled 
visits to the diabetes clinic. The 
procedure was appropriate to collect 
data within the limited time of 2 
months and to abide by the working 
plan of twice a week of the diabetes 
outpatient clinic of MNH. Around 500 
patients attended the clinic during 
the two months of data collection 
among whom we recruited the study 
participants based on predefined 
inclusion criteria. We only included 
T2DM patients who did not have any 
of the known conditions associated 
with microalbuminuria, including 
proteinuria, renal diseases, acute 
illness, hematuria, hepatic and 
heart-related diseases, polyuria, 
urinary tract infection, and 
hypertension. Also, we included 
patients who accepted to sign the 
consent to participate in the study. 
We identified 146 potential 
participants among those who 
attended the clinic during the period 
of data collection using the patient’s 
clinical sheets available at the 
outpatients’ diabetes clinic of the 
hospital. Each potential candidate 
who consented to participate in the 
study provided a urine specimen 
which was screened using dipstick 
strips with 11 parameters. Only 
individuals whose specimens tested 
negative for urinary tract infection 
(leukocytes, nitrites), proteinuria, 
and glycosuria were included in the 
study. In total, we selected 124 
participants after the screening. 
Ethical considerations 
We got the ethical clearance from the 
Muhimbili University of Health and 
Allied Sciences (MUHAS) ethical 
review board and requested 
permission from the MNH 
administration. We explained the 
purpose and the importance of the 
study to the patients before 
enrolment. Participants got hard 
copies of the consent form written in 
Swahili, which is the local language, 
to read and ask questions about 




whatever they could not understand. 
The consented participants signed 
the consent form showing their 




We used a structured form for each 
participant to record information on 
age, sex, and the duration of 
diabetes. We recorded the without 
shoe height and weight of each 
participant for BMI calculation. We 
calculated BMI by taking the weight 
of an individual in kilograms divided 
by the square of his/her height in 
meters. We classified patients' weight 
as the normal weight for BMI of 18.5-
24.9kg/m2, overweight for BMI 
between 25-29.9 kg/m2, and obese 
for BMI of 30 kg/m2 and above.  
 
Laboratory procedures 
Capillary fasting blood glucose was 
tested using Accu-Chek Active 
Glucometer measuring blood glucose 
into mmol/L. A mean value of 7.2 
mmol/L of blood sugar was 
considered normal while the value 
above 7.2 mmol/L was considered as 
high.[19] Urine samples were tested 
for microalbuminuria using 
Microalbumin 2-1 combo strips 
(CLIA waived, Inc. 2-1 
Creatinine/Microalbumin Rapid Test 
Strips) as per the manufacturer's 
instructions. The obtained results of 
albumin and creatinine were used to 
calculate the albumin/ creatinine 
ratio (ACR). The microalbuminuria 
was defined as a value of albumin to 
creatinine ratio ranging from 30-
300mg/g while the value above 




We classified participants according 
to their baseline characteristics that 
are age, gender, BMI, blood sugar 
levels, and the duration of diabetes. 
Then, we cross-tabulated the 
participants’ characteristics with the 
ratios of albuminuria (the outcome 
variable) in three levels (normal, 
micro, macro) to observe its 
prevalence patterns. The chi-square 
test was used to assess whether 
there was a significant association 
between the albuminuria levels by 
the baseline characteristics. Finally, 
we conducted the logistic regression 
analysis test with a 95% level of 
statistical significance to determine 
the factors associated with 
microalbuminuria among the 
baseline characteristics. Age and 
duration of diabetes were used as 
continuous variables while gender, 
BMI, and blood sugar levels were 
used as categorical variables.  
Results  
Baseline characteristics of the 
study participants by gender 
Table 1 presents the baseline 
characteristics by gender for the 124 
T2DM patients that participated in 




the study. Among the participants, 
75 (60.5%) were females and 49 
(39.5%) males. The majority (65.4%) 
were below the age of 60, with a 
quarter being below the age of 50 
(40.3%). Three-quarters of the 
participants had high blood sugar 
levels among which female 
participants had the highest 
percentage (45.2%) compared to male 
participants (29.8%).  
 
Table 1. Baseline characteristics of study participants by gender 
Variable Categories Frequency 





Age (in years) ≤ 49 31(25.0) 16(12.9) 15(12.1) 
50-59 50(40.3) 30(24.3) 20(16.1) 
60-69 34(27.4) 23(18.5) 11(8.9) 
≥70 9(7.3) 6  (4.8) 3(2.4) 
Blood sugar  Normal(≤7.2 
mmol/L) 
31(25.0) 19(15.3) 12(9.7) 
High (≥7.3 mmol/L) 93(75.0) 56(45.2) 37(29.8) 
BMI  Normal weight 43(34.7) 20(16.1) 23 (18.5) 
Overweight 49(39.5) 26(21) 23(18.5) 
Obesity 32 (25.8) 29(23.4) 3(2.4) 
Duration of diabetes 
(in years) 
≤ 4 48(38.7) 29(23.4) 19(15.3) 
5-9 39(31.5) 22(17.7) 17(13.7) 
10-14 23(18.5) 16(12.9) 7(5.6) 
≥15 14(11.3) 8   (6.5) 6  (4.8) 
Concerning the body mass index, 
39.5% were overweight whereas 
25.8% were obese. Also, the body 
mass index was higher in females 
than in males. The majority (70.2%) 
of the patients had diabetes for less 
than ten years among which 38.7% 
had diabetes for five years or less. 
The prevalence of albuminuria  
Table 2 presents the prevalence of 
albuminuria in levels cross-
tabulated with the patients’ baseline 
characteristics, and the chi-square 
test of association between the two. 
The data shows that 35.5% of the 
participants had a normal level of 
urine albumin. Seventy-seven of the 
participants (equivalent to 62.1%) 
had microalbuminuria while 3(2.4%) 
of them had macroalbuminuria. Most 
patients in the 50s and 60s had 
microalbuminuria with a combined 




percentage of 46.8 for the two 
groups.  
 
Table 2. The prevalence of albuminuria by the characteristics of the study 
participants 
   Urine albumin levels  













Gender Females 75 27 (21.8) 47 (37.9) 1 (0.8) 0.585 
Males 49 17 (13.7) 30 (24.2) 2 (1.6)  
Age ≤ 49 31 16 (12.9) 15 (12.1) 0 (0) 0.001* 
50-59 50 20 (16.1) 29 (23.4) 1 (0.8) 
60-69 34 5    (4.1) 29 (23.4) 0 (0) 
≥ 70 9 3    (2.4) 4 (3.2) 2 (1.6) 
Blood 
sugar 
Normal  31 20 (21.0) 11 (8.9) 0 (0)  
0.000* High        93 24 (19.4) 66 (53.2) 3 (2.4) 
 
BMI 
Normal 43 14 (11.3) 28 (22.6) 1 (0.8) 0.944 
Overweight 49 15 (12.1) 33 (26.6) 1 (0.8)  




≤ 4 48 26 (21.0) 22 (17.7) 0 (0)  
0.000* 5-9 39 13 (10.5) 26 (21.0) 0 (0) 
10-14 23 4 (3.2) 18 (14.5) 1 (0.8) 
≥15 14 1 (0.8) 11 (8.9) 2(1.6) 
       
* Significant at 0.05 level 
Likewise, the prevalence of 
microalbuminuria in patients with 
high blood sugar was relatively high, 
comprising 53.2% of all the samples 
tested. The distribution of albumin 
levels was significantly associated 
with the age, blood sugar levels and 
the duration of diabetes (P<0.001). 
However, there was no statistically 
significant difference in the 
distribution of the albumin levels by 
gender and BMI categories. 
 
Correlates of microalbuminuria 
Table 3 presents the results of the 
logistic regression analysis of the 
association between 
microalbuminuria and the selected 
predictors. The results indicate an 
increased risk of microalbuminuria 
as the age of the patient increased. 
Patients aged between 60-69 years 
had 4.66 times the risks of 
microalbuminuria compared to 
patients aged below 50 years (95% 
CI: 1.32-16.51), and the risk 
increased 17.4 times in patients aged 




70 years and above (95% CI: 1.49-
202.87).  Similarly, the risk for 
microalbuminuria increased with the 
duration an individual lived with 
diabetes. Patients who lived with 
diabetes for 10-14 years had 7.89 
times risks of developing 
microalbuminuria compared to those 
who lived with the disease less than 
5 years (95% CI: 1.37-45.59); 
patients with high blood sugar had 
8.09 times risks of microalbuminuria 
compared to those with normal blood 
sugar (95% CI: 2.53-25.86).  
Table 3. Results of the logistic regression analysis of the association 
between microalbuminuria and the selected predictors 
Univariate model Multivariable model 
 Odds  
ratio 
95% CI P- value Odds ratio 95% CI P value 
Age (in years)       
≤ 49 1 - - 1 - - 
50-59 3.03 1.17-7.83 0.022* 1.99 0.66-6.00 0.222 
60-69 4.45 1.53-12.97 0.006* 4.66 1.32-16.51 0.017* 
≥70 32.45 3.80-277.1 0.001* 17.4 1.49-202.87 0.023* 












≤ 4 1 - - 1 - - 
5-9 2.08 0.89- 4.85 0.089 2.31 0.81-6.64 0.119 
10-14 12.67 2.65-60.46 0.001* 7.89 1.37-45.59 0.021* 
≥ 15 7.33 1.47-36.66 0.015* 2.46 0.34-17.87 0.374 
BMI        
Normal weight 1 - - 1 - - 
Overweight 0.96 0.42-2.20 0.923 1.07 0.38-3.01 0.899 
Obese 1.84 0.69-4.90 0.223 0.46 0.10-2.09 0.315 
Blood sugar       
Normal  1 - - 1 - - 
High 10.73 3.92-19.41 0.000* 8.09 2.53-25.86 0.000* 
Gender       
Female 1 - - 1 - - 
Males 1.53 0.72-3.26 0.264 1.17 0.43-3.22 0.753 
* Significant at 95% confidence interval 
 
 




However, there was no statistically 
significant association between the 
prevalence of microalbuminuria and 
the body max index of the patients, 
nor was it associated with gender.  
Discussion   
This study assessed the magnitude of 
microalbuminuria among type 2 
diabetes patients and analyzed its 
correlates to inform the diabetes 
clinics of the need for regular 
microalbuminuria screening. Results 
indicated that the prevalence of  
microalbuminuria among type 2 
diabetes outpatients at MNH was 
62.1%. Our finding is close to that 
observed in earlier studies conducted 
in developing countries similar to 
Tanzania.[10,21] However, this 
prevalence is higher compared to 
what was found 10 years earlier in 
the same hospital.[22] Several 
reasons could explain the difference, 
among which is the ten years-time 
lapse. It is reasonable that in ten 
years many things could have 
happened including an increased 
number of patients, delayed 
diagnosis among others. The other 
reason may be the different methods 
used in the detection of 
microalbuminuria. The mentioned 
study used 24 hours excretion rate 
whereas ours used an albumin to 
creatinine ratio. The 24 hours urine 
albumin excretion rate is considered 
the gold standard method. However, 
due to the challenges of imperfect 
adherence of the patient to the 
protocol, the method is not suitable 
to be used in epidemiological 
research and clinical settings. 
Therefore, the albumin to creatinine 
ratio in a random spot urine sample 
has been the recommended method 
as it is easy, rapid, and accurate.[19] 
 
The study did not indicate the 
association between obesity and 
microalbuminuria, contrary to what 
was reported in other studies where 
obesity was found to be a risk factor 
for microalbuminuria in type 2 
diabetes patients.[9] The lack of 
association could not be attributed to 
the size of the sample of 124 patients, 
as the referenced study used a much 
smaller sample of 60. Rather, the 
reason could be the differences in 
populations, as in our study, T2DM 
patients had the disease for a 
relatively shorter period (mean 
duration of seven years), whereas, in 
the referenced studies, patients had 
had the disease for a much more 
extended period. Equally important, 
is the fact that in a case-control 
study done to evaluate the 
association between obesity and 
microalbuminuria among non-
diabetic patients, a strong 
association between obesity and 
microalbuminuria was reported. The 
same study indicated that 
microalbuminuria was highly 
prevalent among obese subjects 
compared to the controls.[23] It 




seems that this difference may be 
related to factors other than diabetes 
which may be linked to obesity and 
causing microalbuminuria. 
 
The results of the present study also 
show that the association between 
microalbuminuria and gender was 
not statistically significant, which is 
similar to what was reported.[24] 
Nevertheless, Malir Cantt, in 
Pakistan found that 
microalbuminuria was correlated 
with female sex,[25] while a study 
conducted in the Indian population 
reported a statistically significant 
correlation between 
microalbuminuria and male sex.[24] 
Based on these results we can 
assume that these variations in the 
results may be attributed to 
differences in lifestyle, which could 
have exposed men and women 
differently in the different societies 
involved. 
The study shows a significant 
association of microalbuminuria 
with age. This finding is similar to the 
study conducted at a diabetic clinic 
in King Abdulaziz university hospital, 
Saudi Arabia.[26] but contrary to 
what reported in the study 
conducted at Al-Husain Hospital, 
Iraq.[21] These conflicting findings 
may be due to other confounding 
factors than the age of subjects, such 
as dyslipidemia, undiagnosed 
hypertension among others. 
Microalbuminuria is considered to be 
a meaningful early sign of diabetic 
nephropathy, which by itself is one of 
the severe complications of diabetes 
mellitus.[27] Microalbuminuria 
develops after 5-10 years from 
diabetes onset.[28] Consequently, we 
hypothesized that the degree of 
microalbuminuria would increase as 
the number of years an individual 
lived with diabetes would increase.  
The findings from this study 
supported our hypothesis as they 
indicated that the risk of 
microalbuminuria increased with the 
number of years an individual lived 
with diabetes, which agreed with 
other related studies.[29] However, 
some studies, like the one conducted 
by Ibrahim et al., reported no 
association between the duration of 
diabetes and the prevalence of 
microalbuminuria.[21] This 
difference may be due to other factors 
such as poor control of blood sugar 
and being elderly especially 
considering that T2DM is common in 
older people. Another factor to take 
into account is the delayed diagnosis 
of diabetes given that its signs appear 
at an advanced stage.  
 
Last, the study investigated the 
relationship between 
microalbuminuria and blood glucose 
levels.  The data show that T2DM 
patients with high blood glucose 
levels have an increased risk of 
microalbuminuria compared to 
T2DM patients with normal blood 




glucose, just as it was reported 
elsewhere.[30] The patients with high 
blood glucose levels indicate a high 
prevalence of microalbuminuria due 
to that the high blood glucose level 
increases pressure in the kidney, 
which leads to the development of 
microalbuminuria. 
Limitations 
The first limitation is that the study 
did not account for some potential 
confounders like dyslipidemia, HIV, 
and hypertension. Consequently, the 
findings should be interpreted 
considering this limitation. Secondly, 
it was not possible to determine the 
exact date on which a patient 
developed diabetes. Therefore, the 
data presented on the duration of 
diabetes was based on the date a 
patient was diagnosed and 
pronounced to have diabetes. The 
third limitation is that the study was 
conducted at one hospital, and for a 
limited period, meaning that if it 
could have been extended much 
longer and recruiting patients from 
various hospitals, probably the 
findings could have been different. 
However, we remain confident that 
the findings of this study are 
valuable to inform health providers 
and policymakers on the 
improvement of care given to patients 
with diabetes.  
Conclusions and 
Recommendations 
Microalbuminuria is high among 
patients with T2DM. The most 
vulnerable patients are those aged 
between 50 years and 60 years, and 
those with high glucose levels. The 
risk for microalbuminuria increases 
with age and with the duration of 
diabetes. Gender and BMI are not 
significantly associated with 
microalbuminuria. The study 
recommends diabetes clinics to 
conduct regular screening for 
microalbuminuria in T2DM patients 
to inform clinical decisions to prevent 
the risk of developing kidney 
diseases. Screening should be done 
at diagnosis and repeated regularly 
on an annual basis, and proper 
control of blood glucose should be 
emphasized to reduce the risk of 
microalbuminuria and kidney 
damage.  
This study was cross-sectional, and 
the findings are interpreted to the 
design and the associated limitations 
and advantages. We recommend 
further studies to use the findings to 
design a longitudinal study involving 
more extended population coverage. 
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